David Lamond - Aug 15, 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fac for David Lamond
Stock symbol
QNCX
Transactions as of
Aug 15, 2023
Transactions value $
$325,737
Form type
4
Date filed
8/17/2023, 06:08 PM
Previous filing
May 26, 2023
Next filing
Aug 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Purchase $142K +108K +5.84% $1.32 1.95M Aug 15, 2023 By Blue Devil Trust dated 12/03/2010 F1, F2
transaction QNCX Common Stock Purchase $151K +117K +6% $1.29 2.07M Aug 16, 2023 By Blue Devil Trust dated 12/03/2010 F2, F3
transaction QNCX Common Stock Purchase $31.9K +24.8K +1.2% $1.29 2.1M Aug 17, 2023 By Blue Devil Trust dated 12/03/2010 F2, F4
holding QNCX Common Stock 302K Aug 15, 2023 Direct
holding QNCX Common Stock 1.73M Aug 15, 2023 By David A. Lamond Trust dated 2006 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.